154
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

New study shows that extending prophylaxis with Clexane® (enoxaparin sodium injection) to five weeks is more effective than 10 days for reducing the risk of Venous Thromboembolism (VTE) in acutely ill medical patients with reduced mobility

EXCLAIM is the first international study to show that extended thromboprophylaxis reduces VTE risk in acutely-ill medical patients with a statistically significant 44%